Unlike many other multi-national Pharmaceutical companies, Goldshield Pharmaceuticals does not specialise in one therapeutic disease area, but services a broad segment of the Pharmaceutical market across a wide range of therapeutic areas. This core strategy provides a strong base and the potential to optimise future opportunities within these therapeutic areas.

Within many international territories, the population is healthier and people are living longer. One of the core strengths of the Goldshield portfolio is to concentrate on therapies that have chronic repeat usage, which will add long-term value to shareholders. This high, repeat usage strategy will continue to be an area of focus for both organic growth and future potential acquisitions.

As with any successful organisation, people are a core strength and within Goldshield Pharmaceuticals, developing people and maximising their potential is a central principle. These people are the key to developing and implementing successful sales and marketing strategies and have the experience that fully meets the requirements for the achievement of our objectives. Sales and marketing strategies are focused upon implementing activities that can be tightly measured. Spend vs. return is a key element within these strategies throughout the organisation.

Combined with all of these key sales and marketing strategies, tight financial controls are also an essential element of Goldshield's success.